Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis

Clinical trial NCT06857240 · RECRUITING

Trial details

NCT number: NCT06857240
Sponsor: The Cleveland Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatomyositis

Start date: 2025-06-01
Primary completion: 2026-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.